Skip to main content
. 2012 May 1;1(3):271–278. doi: 10.4161/onci.18684

graphic file with name onci-1-271-g3.jpg

Figure 3. Kaplan-Meier estimates of overall survival in non-small cell lung carcinoma (NSCLC) patients bearing the wild type alleles for both TLR4 and P2RX7 (wild type TLR4 and P2RX7) or at least one variant for either TLR4 or P2RX7. Overall survival according to TLR4 and P2RX7 status in all 677 patients (A), in patients subjected to chemotherapy (B) and in untreated patients (C).